Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease

Author:

Baiardini IlariaORCID,Contoli Marco,Corsico Angelo Guido,Scognamillo Carla,Ferri Fabio,Scichilone Nicola,Rogliani Paola,Di Marco Fabiano,Santus Pierachille,Braido Fulvio

Abstract

<b><i>Background:</i></b> Disease awareness is a challenge in the management of chronic obstructive pulmonary disease (COPD). <b><i>Objectives:</i></b> The aim of this analysis was to explore the association between COPD optimal and suboptimal awareness, clinical parameters, and the following patient-reported outcomes: modified Medical Research Council (mMRC), Treatment Satisfaction Questionnaire (TSQM-9), COPD Assessment Test (CAT), Morisky Medication-Taking Adherence Scale (MMAS-4), and Brief Illness Perception Questionnaire (B-IPQ). <b><i>Methods:</i></b> This post hoc analysis of the SAT study included all enrolled patients for whom awareness (Disease Awareness in COPD Questionnaire – DACQ) was assessed at baseline and 12 months. DACQ scores ≥80 were considered an indicator of an optimal awareness. <b><i>Results:</i></b> 367 patients (25.8% women, median age 72 years) were included in the analysis. At enrollment, 74 patients (20.2%) had a DACQ score ≥80. Patients with suboptimal awareness, compared to those in which awareness was optimal, had higher median scores for CAT (<i>p</i> = 0.0001) and mMRC (<i>p</i> = 0.0031), a lower median TSQM-9 global score (<i>p</i> &#x3c; 0.0001), and higher median B-IPQ score (<i>p</i> &#x3c; 0.0001). The proportion of patients who had exacerbations during the previous year was higher in patients with suboptimal COPD awareness than in those with DACQ score ≥80 (42.8 vs. 21.4%, <i>p</i> = 0.0009). During the 12-month observation period, illness perception, adherence, and treatment satisfaction were found to be independent factors significantly associated with level of disease awareness. <b><i>Conclusion:</i></b> The results of our post hoc analysis suggest that patients’ awareness of their COPD disease is related to both clinical outcomes and how they perceive and manage their condition.

Publisher

S. Karger AG

Subject

Pulmonary and Respiratory Medicine

Reference20 articles.

1. Zielinski J, Bednarek M, Górecka D, Viegi G, Hurd SS, Fukuchi Y, et al. Increasing COPD awareness. Eur Respir J. 2006;27(4):833–52.

2. Boehm A, Pizzini A, Sonnweber T, Loeffler-Ragg J, Lamina C, Weiss G, et al. Assessing global COPD awareness with Google trends. Eur Respir J. 2019 Jun 27;53(6):1900351.

3. Seo JY, Hwang YI, Mun SY, Kim JH, Kim JH, Park SH, et al. Awareness of COPD in a high risk Korean population. Yonsei Med J. 2015 Mar;56(2):362–7.

4. Mun SY, Hwang YI, Kim JH, Park S, Jang SH, Seo JY, et al. Awareness of chronic obstructive pulmonary disease in current smokers: a nationwide survey. Korean J Intern Med. 2015 Mar;30(2):191–7.

5. Corli O, Apolone G, Pizzuto M, Cesaris L, Cozzolino A, Orsi L, et al. Illness awareness in terminal cancer patients: an Italian study. Palliat Med. 2009;23(4):354–9.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3